Header Logo

Connection

LAURA MARSH to Parkinson Disease

Back to Details
This is a "connection" page, showing publications LAURA MARSH has written about Parkinson Disease.
LAURA MARSH
Connection Strength
6.327
Parkinson Disease
  1. Physical Violence and Aggression in Parkinson's Disease: A Systematic Review. J Acad Consult Liaison Psychiatry. 2024 Jul-Aug; 65(4):366-378.
    View in: PubMed
    Score: 0.490
  2. Post-Traumatic Stress Disorder and Risk of Degenerative Synucleinopathies: Systematic Review and Meta-Analysis. Am J Geriatr Psychiatry. 2023 11; 31(11):978-990.
    View in: PubMed
    Score: 0.465
  3. Cognitive dysfunction and neuropsychiatric aspects of Parkinson's disease. Prog Brain Res. 2022; 269(1):59-90.
    View in: PubMed
    Score: 0.427
  4. Depression and Parkinson's disease: current knowledge. Curr Neurol Neurosci Rep. 2013 Dec; 13(12):409.
    View in: PubMed
    Score: 0.242
  5. Pharmacologic treatment of anxiety disorders in Parkinson disease. Am J Geriatr Psychiatry. 2013 Jun; 21(6):520-8.
    View in: PubMed
    Score: 0.231
  6. Improving detection of psychiatric disturbances in Parkinson's disease: the role of informants. J Parkinsons Dis. 2013; 3(1):55-60.
    View in: PubMed
    Score: 0.227
  7. Application of depression rating scales in patients with Parkinson's disease with and without co-Occurring anxiety. J Parkinsons Dis. 2013; 3(4):603-8.
    View in: PubMed
    Score: 0.227
  8. Anxiety disorders, physical illnesses, and health care utilization in older male veterans with Parkinson disease and comorbid depression. J Geriatr Psychiatry Neurol. 2012 Dec; 25(4):233-9.
    View in: PubMed
    Score: 0.226
  9. Prevalence of psychotic symptoms in a community-based Parkinson disease sample. Am J Geriatr Psychiatry. 2012 Feb; 20(2):123-32.
    View in: PubMed
    Score: 0.213
  10. Anxiety and self-perceived health status in Parkinson's disease. Parkinsonism Relat Disord. 2011 May; 17(4):249-54.
    View in: PubMed
    Score: 0.199
  11. Familial aggregation of panic disturbances in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2011; 23(4):417-24.
    View in: PubMed
    Score: 0.198
  12. Detection of impulse control disorders in Parkinson disease patients. Neurologist. 2010 Nov; 16(6):406-7.
    View in: PubMed
    Score: 0.195
  13. Validity of the Cornell scale for depression in dementia in Parkinson's disease with and without cognitive impairment. Mov Disord. 2009 Feb 15; 24(3):433-7.
    View in: PubMed
    Score: 0.174
  14. Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: a pilot open-label study. Mov Disord. 2009 Jan 30; 24(2):277-82.
    View in: PubMed
    Score: 0.173
  15. Bridging the Rural Mental Health Gap: Telehealth Delivery of Specialized CBT and MBCT for Veterans With Parkinson's Disease. J Rural Health. 2026 Mar; 42(2):e70175.
    View in: PubMed
    Score: 0.141
  16. Provisional diagnostic criteria for depression in Parkinson's disease: report of an NINDS/NIMH Work Group. Mov Disord. 2006 Feb; 21(2):148-58.
    View in: PubMed
    Score: 0.141
  17. Pilot screening for prodromal Parkinson's disease in post-9/11 Veterans with probable rapid eye movement sleep behavior disorder. Parkinsonism Relat Disord. 2025 Mar; 132:107309.
    View in: PubMed
    Score: 0.131
  18. Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease. Int J Geriatr Psychiatry. 2004 Jan; 19(1):1-8.
    View in: PubMed
    Score: 0.122
  19. Neuropsychiatric aspects of Parkinson's disease: recent advances. Curr Psychiatry Rep. 2003 May; 5(1):68-76.
    View in: PubMed
    Score: 0.116
  20. Ten most commonly asked questions about the psychiatric aspects of Parkinson's disease. Neurologist. 2003 Jan; 9(1):50-6.
    View in: PubMed
    Score: 0.114
  21. Post-Traumatic Stress Disorder is Associated with further Increased Parkinson's Disease Risk in Veterans with Traumatic Brain Injury. Ann Neurol. 2020 07; 88(1):33-41.
    View in: PubMed
    Score: 0.094
  22. Integration and Extension of Specialty Mental Healthcare Services to Community Practice in Parkinson Disease. Am J Geriatr Psychiatry. 2019 07; 27(7):712-719.
    View in: PubMed
    Score: 0.087
  23. Perceived Treatment Status of Fluctuations in Parkinson Disease Impacts Suicidality. Am J Geriatr Psychiatry. 2018 06; 26(6):700-710.
    View in: PubMed
    Score: 0.081
  24. Modeling anxiety in Parkinson's disease. Mov Disord. 2016 Mar; 31(3):310-6.
    View in: PubMed
    Score: 0.070
  25. The longitudinal impact of depression on disability in Parkinson disease. Int J Geriatr Psychiatry. 2016 May; 31(5):458-65.
    View in: PubMed
    Score: 0.068
  26. A Pilot Study of a Cognitive-Behavioral Treatment for Anxiety and Depression in Patients With Parkinson Disease. J Geriatr Psychiatry Neurol. 2015 Sep; 28(3):210-7.
    View in: PubMed
    Score: 0.067
  27. Mental health diagnoses and health care utilization in persons with dementia, Parkinson's disease, and stroke. J Neuropsychiatry Clin Neurosci. 2015; 27(2):e117-21.
    View in: PubMed
    Score: 0.065
  28. Cognitive and motor function in long-duration PARKIN-associated Parkinson disease. JAMA Neurol. 2014 Jan; 71(1):62-7.
    View in: PubMed
    Score: 0.061
  29. Anxiety has specific syndromal profiles in Parkinson disease: a data-driven approach. Am J Geriatr Psychiatry. 2014 Dec; 22(12):1410-7.
    View in: PubMed
    Score: 0.060
  30. Modeling depression in Parkinson disease: disease-specific and nonspecific risk factors. Neurology. 2013 Sep 17; 81(12):1036-43.
    View in: PubMed
    Score: 0.059
  31. Rasch analysis of anxiety scales in Parkinson's disease. J Psychosom Res. 2013 May; 74(5):414-9.
    View in: PubMed
    Score: 0.058
  32. Cognitive behavioral therapy for depression and anxiety in Parkinson's disease: a clinical review. J Parkinsons Dis. 2012; 2(2):135-51.
    View in: PubMed
    Score: 0.053
  33. Gaps in treatment for anxiety in Parkinson disease. Am J Geriatr Psychiatry. 2011 Oct; 19(10):907-8.
    View in: PubMed
    Score: 0.052
  34. Ocular motor and sensory function in Parkinson's disease. Ophthalmology. 2012 Jan; 119(1):178-82.
    View in: PubMed
    Score: 0.052
  35. Anxiety rating scales in Parkinson's disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale. Mov Disord. 2011 Feb 15; 26(3):407-15.
    View in: PubMed
    Score: 0.050
  36. Symptomatology and markers of anxiety disorders in Parkinson's disease: a cross-sectional study. Mov Disord. 2011 Feb 15; 26(3):484-92.
    View in: PubMed
    Score: 0.050
  37. Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study. J Int Neuropsychol Soc. 2011 Jan; 17(1):91-100.
    View in: PubMed
    Score: 0.049
  38. A recommended scale for cognitive screening in clinical trials of Parkinson's disease. Mov Disord. 2010 Nov 15; 25(15):2501-7.
    View in: PubMed
    Score: 0.049
  39. Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. Arch Neurol. 2010 Sep; 67(9):1116-22.
    View in: PubMed
    Score: 0.048
  40. Co-existence of Parkinson's disease and progressive supranuclear palsy: case report and a review of the literature. Neurol Sci. 2011 Feb; 32(1):159-63.
    View in: PubMed
    Score: 0.048
  41. Piloting the NPF data-driven quality improvement initiative. Parkinsonism Relat Disord. 2010 Sep; 16(8):517-21.
    View in: PubMed
    Score: 0.048
  42. Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study. Arch Neurol. 2010 Jun; 67(6):731-8.
    View in: PubMed
    Score: 0.047
  43. Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease. Mov Disord. 2010 May 15; 25(7):805-22.
    View in: PubMed
    Score: 0.047
  44. Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease. J Clin Exp Neuropsychol. 2010 Aug; 32(7):775-9.
    View in: PubMed
    Score: 0.047
  45. Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease. Arch Neurol. 2009 Dec; 66(12):1517-22.
    View in: PubMed
    Score: 0.046
  46. Neuropsychiatric symptoms in Parkinson's disease. Mov Disord. 2009 Nov 15; 24(15):2175-86.
    View in: PubMed
    Score: 0.046
  47. The course of depressive symptoms in early Parkinson's disease. Mov Disord. 2009 Jul 15; 24(9):1306-11.
    View in: PubMed
    Score: 0.045
  48. Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease. Mov Disord. 2009 Jul 15; 24(9):1333-8.
    View in: PubMed
    Score: 0.045
  49. Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations. Mov Disord. 2008 Oct 30; 23(14):2004-14.
    View in: PubMed
    Score: 0.043
  50. Anxiety rating scales in Parkinson's disease: critique and recommendations. Mov Disord. 2008 Oct 30; 23(14):2015-25.
    View in: PubMed
    Score: 0.043
  51. Morphometry of the human substantia nigra in ageing and Parkinson's disease. Acta Neuropathol. 2008 Apr; 115(4):461-70.
    View in: PubMed
    Score: 0.041
  52. Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Mov Disord. 2007 Jun 15; 22(8):1061-8.
    View in: PubMed
    Score: 0.039
  53. Fatigue in Parkinson's disease: a review. Mov Disord. 2007 Feb 15; 22(3):297-308.
    View in: PubMed
    Score: 0.038
  54. Alpha-synuclein and Parkinson's disease: implications from the screening of more than 1,900 patients. Mov Disord. 2005 Sep; 20(9):1191-4.
    View in: PubMed
    Score: 0.034
  55. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases. Neurobiol Aging. 2005 Aug-Sep; 26(8):1183-92.
    View in: PubMed
    Score: 0.033
  56. Apathy in Neurodegenerative Diseases: Recommendations on the Design of Clinical Trials. J Geriatr Psychiatry Neurol. 2015 Sep; 28(3):159-73.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.